Alternative Fc Engineering for BBB Specificity
🧪 Overview
Engineer antibody Fc regions with pH-dependent binding profiles optimized specifically for brain endothelial FcRn interactions. These variants would have reduced systemic FcRn binding but enhanced BBB-specific transport.
Debate provenance: derived from debate `sess_SDA-2026-04-12-gap-debate-20260410-112908-13c403ee` on question: What is the actual quantitative contribution of FcRn-mediated transcytosis to BBB antibody transport in humans?. Consensus signal: domain_expert, medicinal_chemist, skeptic, synthesizer, theorist discussed the mechanism terms Alternative, BBB, Engineering, FCGRT, Specificity, transport. Novelty signal: skeptic-discussed-counterarguments.
🧬 Mechanism
Auto-built from this analysis's top knowledge-graph edges.
graph TD
FCGRT["FCGRT"] -->|regulates| FcRn["FcRn"]
TFRC["TFRC"] -->|regulates| transferrin_receptor["transferrin receptor"]
transferrin_receptor_1["transferrin receptor"] -->|mediates| receptor_mediated_transcy["receptor-mediated transcytosis"]
FcRn_2["FcRn"] -->|regulates| antibody_transcytosis_at_["antibody transcytosis at blood-brain barrier"]
LDLR["LDLR"] -->|regulates| brain_specific_antibody_t["brain-specific antibody transport"]
LRP1["LRP1"] -->|mediates| brain_specific_antibody_t_3["brain-specific antibody transport"]
insulin_receptor["insulin receptor"] -->|mediates| brain_specific_antibody_t_4["brain-specific antibody transport"]
human_FcRn_expression_dif["human FcRn expression differences"] -->|causes| species_translation_gap_i["species translation gap in BBB transport"]
high_dose_antibody_delive["high-dose antibody delivery"] -->|causes| FcRn_transport_saturation["FcRn transport saturation"]
dual_pathway_targeting["dual-pathway targeting"] -->|causes| competitive_binding_at_BB["competitive binding at BBB"]
dual_pathway_targeting_5["dual-pathway targeting"] -->|causes| transport_saturation["transport saturation"]
transferrin_receptor_targ["transferrin receptor targeting"] -->|causes| dose_limiting_toxicity["dose-limiting toxicity"]
style FCGRT fill:#ce93d8,stroke:#333,color:#000
style FcRn fill:#4fc3f7,stroke:#333,color:#000
style TFRC fill:#ce93d8,stroke:#333,color:#000
style transferrin_receptor fill:#4fc3f7,stroke:#333,color:#000
style transferrin_receptor_1 fill:#4fc3f7,stroke:#333,color:#000
style receptor_mediated_transcy fill:#81c784,stroke:#333,color:#000
style FcRn_2 fill:#4fc3f7,stroke:#333,color:#000
style antibody_transcytosis_at_ fill:#4fc3f7,stroke:#333,color:#000
style LDLR fill:#ce93d8,stroke:#333,color:#000
style brain_specific_antibody_t fill:#4fc3f7,stroke:#333,color:#000
style LRP1 fill:#4fc3f7,stroke:#333,color:#000
style brain_specific_antibody_t_3 fill:#4fc3f7,stroke:#333,color:#000
style insulin_receptor fill:#4fc3f7,stroke:#333,color:#000
style brain_specific_antibody_t_4 fill:#4fc3f7,stroke:#333,color:#000
style human_FcRn_expression_dif fill:#4fc3f7,stroke:#333,color:#000
style species_translation_gap_i fill:#4fc3f7,stroke:#333,color:#000
style high_dose_antibody_delive fill:#4fc3f7,stroke:#333,color:#000
style FcRn_transport_saturation fill:#4fc3f7,stroke:#333,color:#000
style dual_pathway_targeting fill:#4fc3f7,stroke:#333,color:#000
style competitive_binding_at_BB fill:#4fc3f7,stroke:#333,color:#000
style dual_pathway_targeting_5 fill:#4fc3f7,stroke:#333,color:#000
style transport_saturation fill:#4fc3f7,stroke:#333,color:#000
style transferrin_receptor_targ fill:#4fc3f7,stroke:#333,color:#000
style dose_limiting_toxicity fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — FCGRT
No curated PDB or AlphaFold mapping for FCGRT yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for FCGRT.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
📊 Market Indicators
💾 Resource Usage
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_round_mining
| source | v1_phase_c_backfill |
| origin_type | debate_round_mining |
| _schema_version | 1 |